Abstract:Objective: We aimed to construct a nomogram prediction model for prognostic assessment of patients with heart failure (HF) based on serological markers and echocardiography. Patients and methods: A total of 200 HF patients admitted to the Second Affiliated Hospital of Nanchang University from January 2018 to January 2020 were selected as the research objects. According to the New York Heart Association (NYHA) cardiac function classification, they were divided into 3 groups, including 65 cases of grade II, 97 cases of grade III, and 38 cases of grade IV. Three groups of echocardiographic parameters were compared [including left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), left ventricular end-systolic volume (LVESV)], differences in serum markers brain natriuretic peptide (BNP), soluble growth-stimulating expression gene 2 (sST2) and the Modified Early Warning Score (MEWS). The patients were divided into two groups according to their clinical outcomes during the follow-up period, including 52 cases in the death group and 148 cases in the survival group. The clinical data of the two groups were compared, and multi-factor logistic regression analysis was performed to screen out the independent risk factors affecting the patient's death. A nomogram model of the patient's mortality risk was constructed based on the independent risk factors. Receiver operating characteristic (ROC) curves and calibration curves were used to evaluate the discrimination and accuracy of the nomogram model. Results: As the cardiac function class of elderly chronic heart failure (CHF) patients increases, LVEDD, LVESD, sST2, and MEWS increase and LVEF decreases (p<0.05). Multifactor analysis results showed that LVEF, LVEDD, sST2, and MEWS were independent factors affecting the clinical outcome of patients. The AUCs predicted using LVEF, LVEDD, sST2, and MEWS alone were 0.738, 0.775, 0.717, 0.831, and 0.768, respectively. There is a certain degree of discrimination, and the model has extremely high accuracy. Conclusions: MEWS, LVEDD, and sST2 increase as the NYHA cardiac function grade of HF patients increases and LVEF decreases, which can reflect the severity of the disease to a certain extent. Additionally, the nomogram model established based on this has a high predictive value for the long-term prognosis of patients and can formulate effective intervention measures for quantitative values.

Nomogram‐based risk assessment model for left ventricular hypertrophy in patients with essential hypertension: Incorporating clinical characteristics and biomarkers

Approach and Accuracy of Electrocardiogram in Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension

Left Ventricular Geometry and the Levels of Plasma B-type Natriuretic Peptide and Serum Procollagen TypeⅢ in Essential Hypertensive Patients

Development of a Nomogram for Screening the Risk of Left Ventricular Hypertrophy in Chinese Hypertensive Patients.

Construction and validation of a nomogram to predict left ventricular hypertrophy in low‐risk patients with hypertension

Risk factors and a predictive model for left ventricular hypertrophy in young adults with salt-sensitive hypertension

Models for improved diagnosis of left ventricular hypertrophy based on conventional electrocardiographic criteria

The Value of Four Anthropometric Indicators for Identifying Left Ventricular Hypertrophy in Chinese Hypertensive Patients

Diagnostic Capability and Influence Factors for a New Electrocardiogram Criterion in the Diagnosis of Left Ventricular Hypertrophy in a Chinese Population.

Development of Heart Failure Risk Prediction Models Based on a Multi-Marker Approach Using Random Forest Algorithms.

Analysis of relevant factors causing left atrial enlargement in the essential hypertensive patients

Clinical Application Value of left Ventricular Pressure-Strain Loop Examination of Myocardial Dysfunction in Patients with Hypertension at Various Risk Levels

Study on the construction of nomogram prediction model for prognostic assessment of heart failure patients based on serological markers and echocardiography

Correlation research of left ventricualr hypertrophy and metabolic index in elderly male patients with hypertension

Risk Factors Related to Left Ventricular Hypertrophy in Elderly Hypertensive Patients

Prevalence and prognostic implication of left ventricular hypertrophy defined by different echocardiographic criteria

Model Embraced Electromechanical Coupling Time for Estimation of Heart Failure in Patients With Hypertrophic Cardiomyopathy

The Evaluation of Right Ventricular Function of Hypertrophic Cardiomyopathy Using Two Dimensional Strain Imaging

Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.

[Prevalence and Relevant Factors on Echocardiographic Left Ventricular Hypertrophy among Community-Based Hypertensive Patients in Shanghai].

Effect of Obesity on Left Ventricular Remodeling and Clinical Outcome in Chinese Patients With Hypertrophic Cardiomyopathy: Assessed by Cardiac MRI